Profile

The laboratory focuses on targeting host factors to generate broad spectrum antivirals and disease pathogenesis modifiers. Studies look at identifying interferon-stimulated genes (ISGs) and their modulators as antivirals against Chikungunya as well as elucidating key molecules involved in vascular endothelial leakage as disease modifiers in severe dengue.